You searched for "Injection"

909 results found

IBSA UK&I launches Perovial®: the first licensed injectable option for men with acute Peyronie’s disease

A clinically supported option for early intervention in a historically underdiagnosed and undertreated condition. IBSA UK&I today (Monday 2 February 2026) announces the launch of Perovial®, the first licensed hyaluronic acid injectable indicated for the management of Peyronie’s disease (PD)...

Cortical stimulation for voiding dysfunction in multiple sclerosis

Voiding dysfunction (VD) increases morbidity in patients with multiple sclerosis (MS), and may be associated with urinary tract infections, stones and renal failure. Catheterisation is required when impaired hand function precludes self-catheterisation, which is associated with further morbidity. In this...

HPV prevalence in invasive penile cancer and association with clinical outcome

Penile cancer risks can be increased by a number of causes such as smoking, phimosis, poor hygiene, multiple sexual partners and history of gential warts or other sexually transmitted diseases. It has been found that circumcised men have a lower...

Rocks of ages

In this series of articles, I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). During a recent junior doctors’ strike, whilst I was re-living my houseman days...

Catheter-free wireless ambulatory bladder pressure monitor

Urodynamics (UDS) is a useful physiological test for the assessment of a range of lower urinary tract disorders. A key limitation of standard UDS is its inability to record measurements of bladder pressure, flow, etc. in real-time situations and the...

Focal therapies in prostate cancer

The standard of care in the management of prostate cancer has, to date, always been to treat the whole gland. This has ranged from surveillance, surgical excision / prostatectomy or external beam radiotherapy / whole gland brachytherapy. With the evolution...

Bridging the gap: the role of ASiT and BSoT in inspiring the next generation of urologists

Urology is a highly technical, rapidly evolving specialty and yet under-represented. At a time of significant innovation driven by advances in minimally invasive surgery, endourology and robotics, it is more important than ever to ensure a strong pipeline of motivated...

European Urology Residents Education Programme (EUREP)

The EAU’s 12th European Urology Residents Education Programme (EUREP) was held from 5-10 September 2014. We were fortunate to attend as part of a small contingent of UK urology registrars who had applied and been selected to attend. The programme...

Simulation-based training of procedural skills: application and integration of educational theories

Educational theories: how familiar are we with these theories and their application in our training? As a Simulation Fellow I have been involved in teaching specific procedural skills and running full immersion simulation sessions. This experience has exposed me to...

Needs of children with a chronic bladder in preparation for transfer to adult care

It is well recognised that transition from paediatric to adult practice is stressful for patients and parents. This paper describes a questionnaire-based study of 80 teenagers with chronic bladder disease (spina bifida exstrophy or other acquired neurogenic bladder condition) of...

Refining management of non-visible haematuria

The optimal evaluation of non-visible haematuria (NVH) continues to be debated, with competing interests of avoidance underdiagnosis and the harms of over-testing. Current National Institute for Health & Care Excellent (NICE) guidance recommends referral for patients ≥60 years with NVH....

Drinks Reception: Latest data from the GALEAS Bladder NHS Real World Evaluation at BAUS (British Association of Urological Surgeons) 2025

Join the team behind GALEAS Bladder, the urinary biomarker test delivering results equivalent to a cystoscopy for the detection and monitoring of bladder cancer, along with special guests, to find out how GALEAS Bladder has performed in the NHS Real World Evaluation. 6 - 7pm, drinks and presentations 7pm onwards, drinks, networking and food